Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


29.01.2024

2 Am J Kidney Dis
2 BMC Neurol
1 Brain
1 Diabetes
2 J Immunol
1 J Neuroimmunol
2 Kidney Int
1 Lancet Neurol
5 Mult Scler
3 Neurology
1 PLoS One
2 Proc Natl Acad Sci U S A
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    PubMed         Abstract available

  2. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    PubMed        


    BMC Neurol

  3. HABIBI MA, Yazdan Panah M, Vaheb S, Olfatifar M, et al
    Validity and reliability of the Persian version of Recce stigma scale in people with multiple sclerosis and its impact on quality of life.
    BMC Neurol. 2024;24:36.
    PubMed         Abstract available

  4. JIN Y, Lan W, Chen X, Liu W, et al
    A rare case of anti-DPPX encephalitis combined with neuroleptospirosis.
    BMC Neurol. 2024;24:34.
    PubMed         Abstract available


    Brain

  5. LAZZAROTTO A, Hamzaoui M, Tonietto M, Dubessy AL, et al
    Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
    Brain. 2024 Jan 24:awae024. doi: 10.1093.
    PubMed         Abstract available


    Diabetes

  6. ILONEN J, Kiviniemi M, El-Amir MI, Nygard L, et al
    Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.
    Diabetes. 2023 Nov 7:db230387. doi: 10.2337/db23-0387.
    PubMed         Abstract available


    J Immunol

  7. DAR AA, Ortega Y, Aktas S, Wu K, et al
    CRL4b Inhibition Ameliorates Experimental Autoimmune Encephalomyelitis Progression.
    J Immunol. 2024 Jan 24:ji2300754. doi: 10.4049/jimmunol.2300754.
    PubMed         Abstract available

  8. YANDAMURI SS, Filipek B, Lele N, Cohen I, et al
    A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases.
    J Immunol. 2024 Jan 22:ji2300015. doi: 10.4049/jimmunol.2300015.
    PubMed         Abstract available


    J Neuroimmunol

  9. THAKOLWIBOON S, Linnoila J, Pittock SJ, Dubey D, et al
    Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome.
    J Neuroimmunol. 2024;387:578293.
    PubMed         Abstract available


    Kidney Int

  10. TANIGUCHI T, Hiwa R, Morinobu A
    Pitfalls in evaluating the impact of persistent hematuria after induction therapy on kidney prognosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Kidney Int. 2024;105:391-392.
    PubMed        

  11. WIMBURY D, Muto M, Bhachu JS, Scionti K, et al
    Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial.
    Kidney Int. 2024;105:381-388.
    PubMed        


    Lancet Neurol

  12. LAURSON-DOUBE J, Helme A, Nonino F, Piggott T, et al
    WHO considers multiple sclerosis treatments essential.
    Lancet Neurol. 2024;23:140.
    PubMed        


    Mult Scler

  13. VIDAL-JORDANA A, Sastre-Garriga J, Tintore M, Rovira A, et al
    Optic nerve topography in multiple sclerosis diagnostic criteria: Existing knowledge and future directions.
    Mult Scler. 2024 Jan 19:13524585231225848. doi: 10.1177/13524585231225848.
    PubMed         Abstract available

  14. TENI FS, Machado A, Fink K, Gyllensten H, et al
    Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden.
    Mult Scler. 2024 Jan 19:13524585231225929. doi: 10.1177/13524585231225929.
    PubMed         Abstract available

  15. JEANTIN L, Januel E, Labauge P, Maillart E, et al
    COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
    Mult Scler. 2024 Jan 21:13524585231218149. doi: 10.1177/13524585231218149.
    PubMed         Abstract available

  16. CAMERLINGO S, Rubinstein F, Celia Ysrraelit M, Correale J, et al
    Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.
    Mult Scler. 2024 Jan 21:13524585231219138. doi: 10.1177/13524585231219138.
    PubMed         Abstract available

  17. HIRT J, Janiaud P, Dublin P, Nicoletti GJ, et al
    Use of pragmatic randomized trials in multiple sclerosis: A systematic overview.
    Mult Scler. 2024 Jan 22:13524585231221938. doi: 10.1177/13524585231221938.
    PubMed         Abstract available


    Neurology

  18. MORGAN A, Li Y, Thompson NR, Milinovich A, et al
    Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis.
    Neurology. 2024;102:e208019.
    PubMed         Abstract available

  19. RADZIK AM, Amezcua L, Anderson A, Gilmore S, et al
    Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort.
    Neurology. 2024;102:e208100.
    PubMed         Abstract available

  20. BRANCH A, Nuaaman MM, Appleton CT, Connaughton DM, et al
    Teaching NeuroImage: Extensive Brainstem and Striatal Involvement in Neuropsychiatric Systemic Lupus Erythematosus.
    Neurology. 2024;102:e209153.
    PubMed        


    PLoS One

  21. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. SUTTER PA, Willis CM, Menoret A, Nicaise AM, et al
    Astrocytic TIMP-1 regulates production of Anastellin, an inhibitor of oligodendrocyte differentiation and FTY720 responses.
    Proc Natl Acad Sci U S A. 2024;121:e2306816121.
    PubMed         Abstract available

  23. AHMED AR, Kalesinskas M, Kaveri SV
    Restoring immune tolerance in pemphigus vulgaris.
    Proc Natl Acad Sci U S A. 2024;121:e2317762121.
    PubMed         Abstract available


    Thyroid

  24. HUWILER VV, Maissen-Abgottspon S, Stanga Z, Muehlebach S, et al
    Selenium Supplementation in Patients with Hashimoto Thyroiditis - A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Thyroid. 2024 Jan 20. doi: 10.1089/thy.2023.0556.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.